[
  {
    "ts": null,
    "headline": "S&P 500 Gains and Losses Today: eBay Soars as Meta Permits Facebook Marketplace Listings",
    "summary": "The S&P 500 added 0.2% on Wednesday, Jan. 8, 2025, as minutes from the most recent Fed policy meeting hinted at a gradual path for rate cuts.",
    "url": "https://finnhub.io/api/news?id=59ba3b872b5f9b78625251918196519ea947d1dc8940d8501a83cda31f1bb642",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736374982,
      "headline": "S&P 500 Gains and Losses Today: eBay Soars as Meta Permits Facebook Marketplace Listings",
      "id": 132337564,
      "image": "https://www.investopedia.com/thmb/LTRhaLEJ2vgeZd2Z41yPKiYDt1s=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-464399583-32e71cef4a8e4d298e85689838507f34.jpg",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The S&P 500 added 0.2% on Wednesday, Jan. 8, 2025, as minutes from the most recent Fed policy meeting hinted at a gradual path for rate cuts.",
      "url": "https://finnhub.io/api/news?id=59ba3b872b5f9b78625251918196519ea947d1dc8940d8501a83cda31f1bb642"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Surges On $900 Million Takeover Of Bolt Medical",
    "summary": "Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.",
    "url": "https://finnhub.io/api/news?id=dc3885b5ed79a0c4bce66da86b3d8bf6944a28067b0895723ecd496ebc25815f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736370527,
      "headline": "Boston Scientific Surges On $900 Million Takeover Of Bolt Medical",
      "id": 132333037,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.",
      "url": "https://finnhub.io/api/news?id=dc3885b5ed79a0c4bce66da86b3d8bf6944a28067b0895723ecd496ebc25815f"
    }
  },
  {
    "ts": null,
    "headline": "J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product",
    "summary": "Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.",
    "url": "https://finnhub.io/api/news?id=281f66352bc2508bc1d0f78680b30e0a197a098504556f9cd1500a74899969b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736361887,
      "headline": "J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product",
      "id": 132320074,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.",
      "url": "https://finnhub.io/api/news?id=281f66352bc2508bc1d0f78680b30e0a197a098504556f9cd1500a74899969b6"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific acquiring Bolt Medical in $443 million deal",
    "summary": "Boston Scientific (BSX) has agreed to acquire Bolt Medical for $443 million in order to expand the former's cardiovascular treatment portfolio. The biomedical device manufacturer Market Domination hosts Julie Hyman and Josh Lipton report on the latest news as Boston Scientific shares get a bump higher on this headline. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.",
    "url": "https://finnhub.io/api/news?id=e5c435a3a5bd1763357dd0735e33c51a8274e6f5a289a6b6d012934ec4894aff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736370029,
      "headline": "Boston Scientific acquiring Bolt Medical in $443 million deal",
      "id": 132333043,
      "image": "https://s.yimg.com/ny/api/res/1.2/2m.E_xEWMkJ9i0qnFYl76w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2025-01/65bd7920-ce01-11ef-bae6-311b50c4996e",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) has agreed to acquire Bolt Medical for $443 million in order to expand the former's cardiovascular treatment portfolio. The biomedical device manufacturer Market Domination hosts Julie Hyman and Josh Lipton report on the latest news as Boston Scientific shares get a bump higher on this headline. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.",
      "url": "https://finnhub.io/api/news?id=e5c435a3a5bd1763357dd0735e33c51a8274e6f5a289a6b6d012934ec4894aff"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add Accuray Stock to Your Portfolio Now",
    "summary": "ARAY's solid product demand and revenue growth raise optimism about the stock.",
    "url": "https://finnhub.io/api/news?id=9a979cae4a2b753e5c24a8b7f8a30275aed4b71d1862a083fa0d82818558037a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736361360,
      "headline": "Here's Why You Should Add Accuray Stock to Your Portfolio Now",
      "id": 132322075,
      "image": "https://media.zenfs.com/en/zacks.com/28fc1568786cf7bd1a1b4ba4d8d32823",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ARAY's solid product demand and revenue growth raise optimism about the stock.",
      "url": "https://finnhub.io/api/news?id=9a979cae4a2b753e5c24a8b7f8a30275aed4b71d1862a083fa0d82818558037a"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal",
    "summary": "On Wednesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease. Cholesterol deposits often create narrowed arteries and may also have a buildup of calcium that can increase the complexity of potential treatments. Lithotripsy is a procedure in which a physician breaks up hardened masses such as calcium to help restore blood flow. The Bolt IVL s",
    "url": "https://finnhub.io/api/news?id=bfd823f1405702f13036e9c7daefc98e8b1c5df1753c3eaf34a79e6214e1e7ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736357110,
      "headline": "Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal",
      "id": 132333049,
      "image": "https://media.zenfs.com/en/Benzinga/6acd54cfc258d25e00e84bb1d7b7b7ca",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "On Wednesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease. Cholesterol deposits often create narrowed arteries and may also have a buildup of calcium that can increase the complexity of potential treatments. Lithotripsy is a procedure in which a physician breaks up hardened masses such as calcium to help restore blood flow. The Bolt IVL s",
      "url": "https://finnhub.io/api/news?id=bfd823f1405702f13036e9c7daefc98e8b1c5df1753c3eaf34a79e6214e1e7ab"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio",
    "summary": "The acquisition expands Boston Scientific's cardiovascular portfolio with Bolt's intravascular lithotripsy system.",
    "url": "https://finnhub.io/api/news?id=744477cee3bf36787941f368e870da3b68fdd5c617b515f70f6c634354e639be",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736356491,
      "headline": "Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio",
      "id": 132333051,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The acquisition expands Boston Scientific's cardiovascular portfolio with Bolt's intravascular lithotripsy system.",
      "url": "https://finnhub.io/api/news?id=744477cee3bf36787941f368e870da3b68fdd5c617b515f70f6c634354e639be"
    }
  },
  {
    "ts": null,
    "headline": "Compelling Reasons to Retain Acadia Healthcare Stock Now",
    "summary": "ACHC remains well-poised for growth, attributable to sustained demand for behavioral healthcare services, as well as growth initiatives such as acquisitions, bed additions and joint ventures.",
    "url": "https://finnhub.io/api/news?id=9d455bc74751e19322718d0b1c40508df615a30829059961114d39f78bd3cdef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736356080,
      "headline": "Compelling Reasons to Retain Acadia Healthcare Stock Now",
      "id": 132333054,
      "image": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ACHC remains well-poised for growth, attributable to sustained demand for behavioral healthcare services, as well as growth initiatives such as acquisitions, bed additions and joint ventures.",
      "url": "https://finnhub.io/api/news?id=9d455bc74751e19322718d0b1c40508df615a30829059961114d39f78bd3cdef"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?",
    "summary": "ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics.",
    "url": "https://finnhub.io/api/news?id=a0f85e6fcda60df631a76a2285b99db1db8b71796afe3bd0bf007f91aeb35d64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736350500,
      "headline": "Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?",
      "id": 132318353,
      "image": "https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics.",
      "url": "https://finnhub.io/api/news?id=a0f85e6fcda60df631a76a2285b99db1db8b71796afe3bd0bf007f91aeb35d64"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?",
    "summary": "Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
    "url": "https://finnhub.io/api/news?id=7f89859d2e21eb99bdddd2bc1b8d7d98a5fd99e4be402c2708c122debea57588",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736345706,
      "headline": "Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?",
      "id": 132333060,
      "image": "https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
      "url": "https://finnhub.io/api/news?id=7f89859d2e21eb99bdddd2bc1b8d7d98a5fd99e4be402c2708c122debea57588"
    }
  },
  {
    "ts": null,
    "headline": "OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains",
    "summary": "OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.",
    "url": "https://finnhub.io/api/news?id=bc4cf4a2c06e33179dc817a56b16aa13b4494c84f65d25ded3745beb3717bbe5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736345460,
      "headline": "OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains",
      "id": 132318744,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.",
      "url": "https://finnhub.io/api/news?id=bc4cf4a2c06e33179dc817a56b16aa13b4494c84f65d25ded3745beb3717bbe5"
    }
  },
  {
    "ts": null,
    "headline": "Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset",
    "summary": "Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.",
    "url": "https://finnhub.io/api/news?id=87d0d384d748ad6d1bf599c10bc381505dc40cf6f51ed49e2b62d2fe67b84efb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736344771,
      "headline": "Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset",
      "id": 132320000,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1297034305/image_1297034305.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.",
      "url": "https://finnhub.io/api/news?id=87d0d384d748ad6d1bf599c10bc381505dc40cf6f51ed49e2b62d2fe67b84efb"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease.",
    "url": "https://finnhub.io/api/news?id=bbab5bbb35829074db88531eefb76a3466ff0b433a387d6627c6bc17ae39fd44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736337600,
      "headline": "Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.",
      "id": 132333065,
      "image": "",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease.",
      "url": "https://finnhub.io/api/news?id=bbab5bbb35829074db88531eefb76a3466ff0b433a387d6627c6bc17ae39fd44"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to buy remaining Bolt Medical stake for up to $664M",
    "summary": "The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.",
    "url": "https://finnhub.io/api/news?id=526975ea50e119400099953ec97ab6fb7ea94ef104766b0e7cd5697cbeed185b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736335619,
      "headline": "Boston Scientific to buy remaining Bolt Medical stake for up to $664M",
      "id": 132333066,
      "image": "https://imgproxy.divecdn.com/80_eRk-7Lf80XDq2Q9e_JyhHdx4CfdjNlu0ZMkOOXzc/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HbG9iYWxfSGVhZHF1YXJ0ZXJzX01hcmxib3JvdWdoX01hc3MuanBn.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.",
      "url": "https://finnhub.io/api/news?id=526975ea50e119400099953ec97ab6fb7ea94ef104766b0e7cd5697cbeed185b"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific : Miriam O’Sullivan Appointed Senior Vice President and Chief Human Resources Officer of Boston Scientific",
    "summary": "Boston Scientific Corporation announced today that Miriam O'Sullivan has been promoted to senior vice president and chief human resources officer at Boston Scientific. Miriam...",
    "url": "https://finnhub.io/api/news?id=0f7387cdc766e561c8f6ee2f0dd63adcdd2a2c6fc012faa42278e6eaefa82f9c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736333944,
      "headline": "Boston Scientific : Miriam O’Sullivan Appointed Senior Vice President and Chief Human Resources Officer of Boston Scientific",
      "id": 132316967,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific Corporation announced today that Miriam O'Sullivan has been promoted to senior vice president and chief human resources officer at Boston Scientific. Miriam...",
      "url": "https://finnhub.io/api/news?id=0f7387cdc766e561c8f6ee2f0dd63adcdd2a2c6fc012faa42278e6eaefa82f9c"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Falls On Surprise Jobs Data, Fed Minutes Next; Nvidia Rebounds From Key Level",
    "summary": "Dow Jones Falls On Surprise Jobs Data, Fed Minutes Next; Nvidia Rebounds From Key Level",
    "url": "https://finnhub.io/api/news?id=fd7f9e16d93263d86ff41f1cab73ad9977e8789ae3de2db4c7a1dc12dd8d453c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736330267,
      "headline": "Dow Jones Falls On Surprise Jobs Data, Fed Minutes Next; Nvidia Rebounds From Key Level",
      "id": 132320907,
      "image": "",
      "related": "BSX",
      "source": "DowJones",
      "summary": "Dow Jones Falls On Surprise Jobs Data, Fed Minutes Next; Nvidia Rebounds From Key Level",
      "url": "https://finnhub.io/api/news?id=fd7f9e16d93263d86ff41f1cab73ad9977e8789ae3de2db4c7a1dc12dd8d453c"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to Buy Rest of Bolt Medical for $443 Million",
    "summary": "By Colin Kellaher Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and...",
    "url": "https://finnhub.io/api/news?id=bdbc03c686d4660c6b2cb87e648e57aec6ab6d870b7aa6fd3fa20b427b1b6a93",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736321664,
      "headline": "Boston Scientific to Buy Rest of Bolt Medical for $443 Million",
      "id": 132314954,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and...",
      "url": "https://finnhub.io/api/news?id=bdbc03c686d4660c6b2cb87e648e57aec6ab6d870b7aa6fd3fa20b427b1b6a93"
    }
  }
]